News
Poxel Reports Cash and Revenue for the Full Year 2022 and Provides Corporate Update
Regulatory News:
POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic
EQS-News: Abivax to present blood and rectal tissue data from UC patients treated with obefazimod at the 18th Congress of ECCO
GenSight Biologics Announces 1 Year Safety Data and Efficacy Signals from PIONEER Phase I/II Clinical Trial of GS030, an Optogenetic Treatment Candidate for Retinitis Pigmentosa
Regulatory News:
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal
RUBIS: Capital increase reserved for Group’s employees
Dassault Systèmes’ 3DEXPERIENCE World 2023: Connecting Emotion, Innovation and Creation for a More Sustainable World
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) (Paris:DSY) today announced that 3DEXPERIENCE World 2023, its annual event dedicated to the 3DEXPERIENCE Works and SOLIDWORKS community
Voyageurs du Monde: Profits up in 2022 and sharp increase in bookings for 2023
Sartorius Stedim Biotech SA: Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 1.44 euros per share to the Annual Shareholders’ Meeting
GEVELOT S.A.: Weekly report of share buyback February 7, 2023
RUBIS: Q4 2022 trading update, stable volumes, solid gross profit growth
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
RUBIS: Leroy Merlin chooses Photosol, a Rubis subsidiary, as green electricity supplier to power its French sites
Dassault Systèmes Developed a New Data Science Solution to Allow Renault Group to Optimize Vehicle Costs
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced that Renault Group is leveraging the data science capabilities of Dassault Systèmes’ 3DEXPERIENCE platform to understand the
Sensorion Will Present Two Posters at the Association for Research in Otolaryngology ARO 46th Annual MidWinter Meeting
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within
ABIVAX: NOTICE TO HOLDERS OF BONDS CONVERTIBLE AND/OR EXCHANGEABLE INTO NEW AND/OR EXISTING SHARES (OCEANES) WITH A NOMINAL VALUE OF EUR 24,999,975.99
Sensorion and EVEON Collaborating to Develop an Injection System for the Delivery of Gene Therapy Treatments Into the Inner Ear
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within
Valbiotis gibt positive Ergebnisse der klinischen Studie zur Bioverfügbarkeit und Wirkungsweise von TOTUM•854 gegen Bluthochdruck bekannt
Pflichtmitteilung:
Valbiotis (FR0013254851 - ALVAL, PEA / KMU-qualifiziert) (Paris:ALVAL), ein kommerziell ausgerichtetes Forschungs- und Entwicklungsunternehmen, das sich auf wissenschaftliche
Valbiotis Announces Positive Results in the Bioavailability and Mode of Action TOTUM•854 Clinical Study, Against High Blood Pressure
Regulatory News:
Valbiotis (FR0013254851 – ALVAL, PEA / SME eligible) (Paris:ALVAL), a commercially oriented Research and Development company, with a commercial purpose, committed to scientific
GEVELOT S.A.: Weekly report of share buyback January 30 01 2023
Verimatrix Secure Delivery Plattform feiert ihr erstes Jahr mit Milliarden von Lizenzen für die Videoübertragung
Verimatrix, (Euronext Paris: VMX), der führende Anbieter von Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass seineVerimatrix Secure Delivery Plattform in weniger als
Verimatrix Secure Delivery Platform Marks Its First Year with Billions of Video Viewership Licenses Served
Regulatory News:
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced its Verimatrix Secure Delivery
Axway Software: Upward Revision of 2022 Annual Targets
Regulatory News:
Axway (Paris:AXW) today announces an upward revision of its organic growth and profitability guidance for the fiscal year ended December 31, 2022. While the company will present
Poxel Receives Orphan Drug Designation from the European Commission for PXL770 and PXL065 for Treatment of Adrenoleukodystrophy
POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including